Mature Virus-Like Particles of Flaviviruses Vaccine

Sun, 19 Apr 2026 03:22:43 +0000
Intellectual Property

The EPO published patent application EP3976768A1, filed by Chiang Mai University and NSTDA, covering mature virus-like particles (VLPs) of flaviviruses for use as vaccines. The invention relates to the production of immunogenic VLP compositions and methods for preventing flavivirus infections. The patent designates 33 European states including major markets such as DE, FR, GB, IT, and ES.